Approval · Notice of Compliance 3853 · 1997
BONDRONAT: Notice of Compliance 3853
Issued August 27, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3853
- Date
- August 27, 1997
- Company
- Boehringer Mannheim (Canada) LteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BONDRONAT | 02232770 | Cancelled Post Market |
Medicinal ingredients
- IBANDRONATE 1 MG per ML